Journals / Turkish Thoracic Journal / 2015 / Cilt: 16 - Sayı: 2

The Prevalence of allergic diseases and associated risk factors in school-age children and adults in Erzurum, Turkey

Pages
68–72
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The identifcation of regional risk factors and taking preventive measures in this regard may provide a reduction in the incidence of allergic diseases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVES: Allergic diseases are a major public health problem, owing to their socioeconomic burden and high frequency.
📊
Key Findings & Data:MATERIAL AND METHODS: Primary school students aged 11-12 years old flled out the International Study of Asthma and Allergies in Childhood (ISAAC) phase II questionnaire, and their parents flled out the European Community Respiratory Health Survey (ECRHS) questionnaire by themselves.
💡
Conclusion & Impact:The identifcation of regional risk factors and taking preventive measures in this regard may provide a reduction in the incidence of allergic diseases.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

OBJECTIVES: Allergic diseases are a major public health problem, owing to their socioeconomic burden and high frequency. The aim of this study was to assess the prevalence and risk factors of allergic diseases in adults and children in the province of Erzurum. MATERIAL AND METHODS: Primary school students aged 11-12 years old flled out the International Study of Asthma and Allergies in Childhood (ISAAC) phase II questionnaire, and their parents flled out the European Community Respiratory Health Survey (ECRHS) questionnaire by themselves. We enrolled 494 questionnaires for ISAAC and 946 for ECRHS. RESULTS: The survey response rates were 91.8% for ISAAC and 87% for ECRHS. The frequencies of doctor-diagnosed asthma, allergic rhinitis, conjunctivitis, atopic dermatitis, and food allergy in children were 11.9%, 8.9%, 27.3%, 3.6%, and 6.5%, respectively. In adults, the rates of wheezing in the chest, accompanying shortness of breath, and wheezing in the absence of fu within the last 12 months were 8%, 8%, and 5.5%, respectively, whereas the rate of asthma attack in the last 12 months was 2.9%, the rate of asthma medication usage was 2.6%, and the frequency of allergic rhinitis was 1.6%. The determined risk factors for childhood were duration of attending a nursery for asthma (p=0.02, OR=2.51, 95% CI=1.14-5.53), having ever been to a nursery for atopic dermatitis (p=0.02, OR=3.83, 95% CI=1.24-11.8), and a family history of rhinitis for food allergy (p=0.01, OR=2.94, 95% CI=1.13-6-57). CONCLUSION: The prevalence of allergic diseases in children and adults in Erzurum was found to be lower than in studies conducted throughout Turkey and in western regions of the Country. Going to a nursery, the length of nursery education, and a family history of rhinitis were identifed as the risk factors for allergic diseases in children. The identifcation of regional risk factors and taking preventive measures in this regard may provide a reduction in the incidence of allergic diseases.

🔖

Cite This Article

BAÇÇIOĞLU, A., SÖĞÜT, A., KILIÇ, Ö., BEYHUN, N. E. (2015). The Prevalence of allergic diseases and associated risk factors in school-age children and adults in Erzurum, Turkey. Turkish Thoracic Journal, Cilt: 16 - Sayı: 2, 68–72. https://ajindex.com/articles/418156

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Türk Toraks Derneği. Astım tanı ve tedavi rehberi. Turkish Tho - racic J 2010;11:6-60
  2. The international study of asthma and allergies in childhood (ISAAC) steering committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivits, and atopic eczema: ISAAC. Lancet 1998;351:1225-32. [CrossRef] 3. Global strategy for asthma management and prevention (updat- ed 2009). The Global Initiative for Asthma (GINA). http://www. ginasthma.com/GuidelinesResources.asp
  3. Celik G, Sin B, Keskin S, et al. Risk factors determining allergic airway diseases in Turkish subjects. J Asthma 2002;39:383-90. [CrossRef] 5. Kurt E, Metintas S, Basyigit I, et al. Prevalence and risk factors of allergies in Turkey (PARFAIT): results of a multicentre cross-sec - tional study in adults. Eur Respir J 2009;33:724-33. [CrossRef] 6. Asher MI, Keil U, Anderson HR, et al. International study of asthma and allergies in childhood (ISAAC): rationale and meth- ods. Eur Respir J 1995;8:483-91. [CrossRef] 7. Burney PGJ, Luczynska C, Chinn S, Jarvis D. The European commu - nity respiratory health survey. Eur Respir J 1994;7:954-60. [CrossRef] 8. Civelek E, Cakir B, Boz AB, et al. Extent and burden of allergic diseases in elementary schoolchildren: A national multicenter study. J Investig Allergol Clin Immunol 2010;20:280-8
  4. Turgut Ş. Uluslararası çocukluk çağı astım ve alerjileri (ISAAC) esaslarına göre İzmir ili 9-11 yaş çocuklarında astım, rinit, egzama ve atopi prevalansının belirlenmesi [Tez]. İzmir: Dokuz Eylül Üniv; 2003
  5. Cetemen A, Yenigün A. Aydın il merkezinde okul çocuklarında astım ve allerjik hastalıkların prevalansı. Asthma Allergy Immu - nol 2012;10:84-92
  6. Lai CKW, Beasley R, Crane J, the ISAAC phase three study group. Global variation in the prevalence and severity of asthma symp- toms: Phase three of the international study of asthma and aller- gies in childhood (ISAAC). Thorax 2009;64:476-83. [CrossRef] 12. Odhiambo JA, Williams HC, Clayton TO, the ISAAC phase three study group. Global variations in prevalence of eczema symp - toms in children from ISAAC Phase Three. J Allergy Clin Immu- nol 2009;124:1251-8. [CrossRef] 13. Saraçlar Y, Çetinkaya F, Tuncer A, et al. The prevalence of self- reported asthma and respiratory symptoms in Ankara, Turkey. Respiratory Med 1997;91:461-3. [CrossRef] 14. Mirici A, Sağlam L, Kaynar H, et al. The prevalence of asthma symptoms among the adult population in Erzurum, Turkey. Sol - unum 2002;4:454-7. 15.